Bracco Imaging Receives Regulatory Approval in China for SonoVue® in the Assessment of Fallopian Tube Patency Provided by PR Newswire Aug 6, 2025, 12:00:00 AM Bracco Imaging Receives Regulatory ...

Due to a lack of effective screening and diagnostic tools, more than three-fourths of ovarian cancer cases are not found until the cancer is in an advanced stage. As a result, fewer than half of all ...

Researchers used OCT to uncover new insights into how the oviduct transports preimplantation embryos toward the uterus for pregnancy. They captured this in vivo 3D OCT image, which shows the mouse ...

Recent findings that the most common kind of ovarian cancer may start in the fallopian tubes could have implications for the prevention, diagnosis and treatment of the disease subtype. A study ...

MILAN, Aug. 5, 2025 /CNW/ -- Bracco Imaging, a global leader in diagnostic imaging, today announced that its ultrasound contrast agent SonoVue ® has been approved by the China's National Medical ...

New indication of SonoVue ® supports non-invasive assessment of female infertility through contrast-enhanced ultrasound in China MILAN, Aug. 6, 2025 /PRNewswire/ -- Bracco Imaging, a global leader in ...